Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications
A Gougol, P Kwo, W Pike, M Farokhnia, G Hui, S Gombar, B Mirminachi
Alimentary Pharmacology & Therapeutics (2026)
Details
Formatted
A Gougol, P Kwo, W Pike, M Farokhnia, G Hui, S Gombar, B Mirminachi. Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70596 BibTeX
@article{pike2026real,
title = {Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications},
author = {Gougol, A and Kwo, P and Pike, W and Farokhnia, M and Hui, G and Gombar, S and Mirminachi, B},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70596},
}
RIS
TY - JOUR
AU - Gougol, A
AU - Kwo, P
AU - Pike, W
AU - Farokhnia, M
AU - Hui, G
AU - Gombar, S
AU - Mirminachi, B
TI - Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications
JO - Alimentary Pharmacology & Therapeutics
PY - 2026
DO - 10.1111/apt.70596
ER -
- Publication Type
- Journal Article
- Journal
- Alimentary Pharmacology & Therapeutics
- Date Published
- March 11, 2026
- Digital Object Identifier
- 10.1111/apt.70596
- PubMed Identifier
- 41813606